Effects of resolvin D1 on inflammatory responses and oxidative stress of lipopolysaccharide-induced acute lung injury in mice

Chinese Medical Journal

Volumn 127, Issue 5, 2014, Pages 803-809

  Wang, Lei ^a   Yuan, Rui Xia ^b   Yao, Cheng Yue ^a   Wu, Qing Ping ^a   Christelle, Marie ^a   Xie, Wan Li ^a   Zhang, Xing Cai ^a   Sun, Wei ^a   Wang, Hui Qing ^a   Yao, Shang Long ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SHENZHEN PEOPLE'S HOSPITAL   (China)

Author keywords

Acute lung injury; Oxidative stress; Resolvin D1; Resolvins

Indexed keywords

ANTIINFLAMMATORY AGENT; HEME OXYGENASE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MALONALDEHYDE; MYELOPEROXIDASE; RESOLVIN D1; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; DOCOSAHEXAENOIC ACID; PEROXIDASE;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HISTOPATHOLOGY; INFLAMMATION; LIPID PEROXIDATION ASSAY; LUNG LAVAGE; LUNG PARENCHYMA; LUNG WEIGHT; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; TOXICITY;

ACUTE LUNG INJURY; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; DOCOSAHEXAENOIC ACIDS; INTERLEUKIN-10; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; OXIDATIVE STRESS; PEROXIDASE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84896877605     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20131044     Document Type: Article

References (28)

1. Chung F, Mueller D. Physical therapy management of ventilated patients with acute respiratory distress syndrome or severe acute lung injury. Physiother Can 2011; 63: 191-198.
2. Hecker M, Weigand MA, Mayer K. Acute respiratory distress syndrome. Internist (Berl) 2012; 53: 557-566.
3. Puneet P, Moochhala S, Bhatia M. Chemokines in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2005; 288: L3-L15.
4. Mclntyre RC Jr, Sheridan B, Agrafojo J, Fullerton DA. Selective inhibition of receptor-mediated pulmonary vasorelaxation in endotoxin-induced acute lung injury. Shock 1997; 7: 36-41.
5. Mittal, Neha, Sanyal, Sankar Nath. Therapeutic role of surfactant during mitochondrial membrane mediated apoptosis in endotoxin induced acute respiratory distress syndrome. Am J Biomed Sci 2012; 4: 60-69.
6. Serhan CN, Arita M, Hong S, Gotlinger K. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids 2004; 39: 1125-1132.
7. Duffield JS, Hong S, Vaidya VS, Lu Y, Fredman G, Serhan CN, et al. Resolvin D series and protectin D1 mitigate acute kidney injury. J Immunol. 2006; 177: 5902-5911.
8. Hong S, Gronert K, Devchand PR, Moussignac RL, Serhan CN. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J Biol Chem 2003; 278: 14677-14687.
9. Recchiuti A, Krishnamoorthy S, Fredman G, Chiang N, Serhan CN. MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits. FASEB J 2011; 25: 544-560.
10. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 2002; 196: 1025-1037.
11. Wang B, Gong X, Wan JY, Zhang L, Zhang Z, Li HZ, et al. Resolvin D1 protects mice from LPS-induced acute lung injury. Pulm Pharmacol Ther 2011; 24: 434-441.
12. Kasuga K, Yang R, Porter TF, Agrawal N, Petasis NA, Irimia D, et al. Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution. J Immunol 2008; 181: 8677-8687.
13. Krishnamoorthy S, Recchiuti A, Chiang N, Yacoubian S, Lee CH, Yang R, et al. Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc Natl Acad Sci U S A 2010; 107: 1660-1665.
14. Jin Y, Arita M, Zhang Q, Saban DR, Chauhan SK, Chiang N, et al. Antiangiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. Invest Ophthalmol Vis Sci 2009; 50: 4743-4752.
15. Merched AJ, Ko K, Gotlinger KH, Serhan CN, Chan L. Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J 2008; 22: 3595-3606.
16. Sun YP, Oh SF, Uddin J, Yang R, Gotlinger K, Campbell E, et al. Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J Biol Chem 2007; 282: 9323-9334.
17. Schwab JM, Chiang N, Arita M, Serhan CN. Resolvin E1 and protectin D1 activate inflammationresolution programmes. Nature 2007; 447: 869-874.
18. Jansson AH, Eriksson C, Wang X. Lung inflammatory responses and hyperinflation induced by an intratracheal exposure to lipopolysaccharide in rats. Lung 2004; 182: 163-171.
19. Hocaoglu C, Kural B, Aliyazi{dotless}ci{dotless}oglu R, Deger O, Cengiz S. IL-1β, IL-6, IL-8, IL-10, IFN-γ, TNF-α and its relationship with lipid parameters in patients with major depression. Metab Brain Dis 2012; 27: 425-430.
20. Gosain A, Gamelli RL. A primer in cytokines. J Burn Care Rehabil 2005; 26: 7-12.
21. Freire-de-Lima CG, Xiao YQ, Gardai SJ, Bratton DL, Schiemann WP, Henson PM. Apoptotic cells, through transforming growth factor-beta, coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages. J Biol Chem 2006; 281: 38376-38384.
22. Hart SP, Dransfield I, Rossi AG. Phagocytosis of apoptotic cells. Methods 2008; 44: 280-285.
23. Nathan C, Ding A. Nonresolving inflammation. Cell 2010; 140: 871-882.
24. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-376.
25. Grigg JM, Savill JS, Sarraf C, Haslett C, Silverman M. Neutrophil apoptosis and clearance from neonatal lungs. Lancet 1991, 338: 720-722.
26. Morcillo EJ, Estrela J, Cortijo J. Oxidative stressandpulmonary inflammation: pharmacological interventionwith antioxidants. Pharmacol Res 1999; 40: 393-404.
27. Sun WH, Liu F, Chen Y, Zhu YC. Hydrogen sulfide decreases the levels of ROS by inhibiting mitochondrial complex IV and increasing SOD activities in cardiomyocytes under ischemia/reperfusion. Biochem Biophys Res Commun 2012; 421: 164-169.
28. Senthil Kumar KJ, Liao JW, Xiao JH, Gokila Vani M, Wang SY. Hepatoprotective effect of lucidone against alcohol-induced oxidative stress in human hepatic HepG2 cells through the up-regulation of HO-1/Nrf-2 antioxidant genes. Toxicol In Vitro 2012; 26: 700-708.